Acquisition by John Childs of 16592 shares of Biohaven Pharmaceutical at 38.8 subject to Rule 16b-3

TQAIX Fund  USD 51.17  0.07  0.14%   
Slightly above 56% of T Rowe's investor base is looking to short. The analysis of overall sentiment of trading T Rowe Price mutual fund suggests that many investors are alarmed at this time. T Rowe's investing sentiment can be driven by a variety of factors including economic data, T Rowe's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Biohaven Pharmaceutical Holding Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 16592 stock option (right to buy) at 38.8 of Biohaven Pharmaceutical by John Childs on 20th of November 2024. This event was filed by Biohaven Pharmaceutical Holding with SEC on 2024-04-30. Statement of changes in beneficial ownership - SEC Form 4

T Rowe Fundamental Analysis

We analyze T Rowe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T Rowe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T Rowe based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

T Rowe is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

T Rowe Price Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with T Rowe mutual fund to make a market-neutral strategy. Peer analysis of T Rowe could also be used in its relative valuation, which is a method of valuing T Rowe by comparing valuation metrics with similar companies.

Other Information on Investing in TQAIX Mutual Fund

T Rowe financial ratios help investors to determine whether TQAIX Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TQAIX with respect to the benefits of owning T Rowe security.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios